tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NTLA Stock Latest News

Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
Market NewsCathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
52m ago
TTD
BEAM
Intellia Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Intellia Therapeutics’ Earnings Call: Progress Amid Challenges
9h ago
NTLA
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
PremiumThe Fly
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
17h ago
BL
BX
Intellia Therapeutics price target lowered to $9 from $14 at RBC Capital
PremiumThe Fly
Intellia Therapeutics price target lowered to $9 from $14 at RBC Capital
18h ago
NTLA
Intellia Therapeutics price target lowered to $27 from $33 at Oppenheimer
PremiumThe Fly
Intellia Therapeutics price target lowered to $27 from $33 at Oppenheimer
20h ago
NTLA
Intellia: Patient who experienced Grade 4 liver safety event has passed away
PremiumThe FlyIntellia: Patient who experienced Grade 4 liver safety event has passed away
20h ago
NTLA
Intellia Therapeutics reports Q3 EPS (92c) vs. ($1.34) last year
Premium
The Fly
Intellia Therapeutics reports Q3 EPS (92c) vs. ($1.34) last year
20h ago
NTLA
Intellia Therapeutics price target lowered to $4 from $9 at Baird
Premium
The Fly
Intellia Therapeutics price target lowered to $4 from $9 at Baird
21h ago
NTLA
Intellia Therapeutics: Hold Rating Amid Safety Concerns and Regulatory Challenges
PremiumRatings
Intellia Therapeutics: Hold Rating Amid Safety Concerns and Regulatory Challenges
22h ago
NTLA
Intellia Therapeutics price target lowered to $12 from $17 at Wells Fargo
PremiumThe Fly
Intellia Therapeutics price target lowered to $12 from $17 at Wells Fargo
22h ago
NTLA
Intellia Therapeutics price target lowered to $21 from $29 at Citizens JMP
PremiumThe Fly
Intellia Therapeutics price target lowered to $21 from $29 at Citizens JMP
23h ago
NTLA
Intellia Therapeutics price target lowered to $14 from $24 at Barclays
PremiumThe Fly
Intellia Therapeutics price target lowered to $14 from $24 at Barclays
23h ago
NTLA
Cautious Hold Rating on Intellia Therapeutics Amid Safety Concerns and Regulatory Uncertainty
PremiumRatingsCautious Hold Rating on Intellia Therapeutics Amid Safety Concerns and Regulatory Uncertainty
24h ago
NTLA
Intellia Therapeutics downgraded to Underweight from Neutral at JPMorgan
Premium
The Fly
Intellia Therapeutics downgraded to Underweight from Neutral at JPMorgan
24h ago
NTLA
Intellia Therapeutics: Buy Rating Affirmed Amid HAE Program Optimism Despite ATTR Setback
Premium
Ratings
Intellia Therapeutics: Buy Rating Affirmed Amid HAE Program Optimism Despite ATTR Setback
1d ago
NTLA
Cathie Wood Pours into Veracyte Stake ahead of Earnings Beat, Slashes Biotech Holdings
PremiumMarket News
Cathie Wood Pours into Veracyte Stake ahead of Earnings Beat, Slashes Biotech Holdings
3d ago
TXG
CRSP
Intellia Therapeutics: Buy Rating Backed by MAGNITUDE Trial Resumption and Promising Data Releases
PremiumRatings
Intellia Therapeutics: Buy Rating Backed by MAGNITUDE Trial Resumption and Promising Data Releases
4d ago
NTLA
Cathie Wood Cuts Stake in Palantir Stock (PLTR) Ahead of Q3, Loads Up on Bullish (BLSH) and Intellia (NTLA)
PremiumMarket News
Cathie Wood Cuts Stake in Palantir Stock (PLTR) Ahead of Q3, Loads Up on Bullish (BLSH) and Intellia (NTLA)
5d ago
BLSH
KTOS
DoorDash, Microsoft, Intellia, Upwork, Qorvo: Trending by Analysts
PremiumWeekend Updates
DoorDash, Microsoft, Intellia, Upwork, Qorvo: Trending by Analysts
7d ago
DASH
MSFT
Intellia Therapeutics downgraded to Neutral from Buy at BofA
PremiumThe FlyIntellia Therapeutics downgraded to Neutral from Buy at BofA
8d ago
NTLA
Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
Premium
The Fly
Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
9d ago
BEAM
NTLA
Intellia Therapeutics price target lowered to $18 from $25 at H.C. Wainwright
Premium
The Fly
Intellia Therapeutics price target lowered to $18 from $25 at H.C. Wainwright
9d ago
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >